Lung cancer combo therapy: does adding chemo to immunotherapy help?

NCT ID NCT04547504

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This French phase 3 trial compares pembrolizumab alone versus pembrolizumab plus chemotherapy as a first treatment for advanced non-small-cell lung cancer with high PDL1 levels (50% or more). About 349 participants are enrolled. The goal is to see if the combination reduces early cancer growth better than immunotherapy alone.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Pembrolizumab (immunotherapy) with or without platinum-based chemotherapy (cisplatin or carboplatin plus pemetrexed or paclitaxel)

What this could lead to

If successful, this could show that adding chemotherapy to pembrolizumab reduces early cancer progression and improves progression-free survival for people with advanced NSCLC and high PDL1 levels.

What could go wrong

This is a phase 3 trial, but results are not yet reported. Adding chemotherapy increases side effects, and it is uncertain whether the combination will prove superior to pembrolizumab alone.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON-SMALL-CELL LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

non-small cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • APHP - Hôpital Cochin

    Paris, 75014, France

  • CH Intercommunal de Créteil

    Créteil, 94010, France

  • CH La Roche Sur Yon - CHD Les Oudairies

    La Roche-sur-Yon, 85000, France

  • CH La Réunion - Site Félix Guyon

    Saint-Denis, 97400, France

  • CH MEAUX

    Meaux, 77108, France

  • CH d'Annecy-genevois

    Pringy, 74374, France

  • CH de Lorient - Hôpital du Scorff

    Lorient, 56100, France

  • CH du Pays d'Aix

    Aix-en-Provence, 13616, France

  • CHRU de Brest

    Brest, 29609, France

  • CHU AMIENS - Hôpital Sud

    Amiens, 80054, France

  • CHU Bordeaux - Hôpital du Haut Levêque

    Pessac, 33604, France

  • CHU La Réunion - Groupe Hospitalier Sud

    Saint-Pierre, 97410, France

  • CHU MARSEILLE_ Hopital Nord

    Marseille, 13915, France

  • CHU RENNES - Hôpital Pontchailloux

    Rennes, 35033, France

  • CHU ROUEN - Hôpital Charles Nicolle

    Rouen, 76031, France

  • Centre Hospitalier Métropole Savoie

    Chambéry, 73000, France

  • Centre Hospitalier de Cornouaille

    Quimper, 29000, France

  • Centre Léon Berard

    Lyon, 69008, France

  • Centre de lutte contre le cancer - Centre François Baclesse

    Caen, 14000, France

  • Ch Villefranche Sur Saone

    Villefranche-sur-Saône, 69655, France

  • Chu Angers

    Angers, 49033, France

  • Chu Dupuytren

    Limoges, 87042, France

  • Hôpital Européen Marseille

    Marseille, 13003, France

  • Hôpital d'Instruction des Armées Toulon - Saint Anne

    Toulon, 83041, France

  • Institut Gustave Roussy

    Villejuif, 94800, France

  • Institut Paoli-Calmette

    Marseille, 13000, France

  • Institut de Cancérologie Strasbourg Europe

    Strasbourg, 67200, France

  • SAINT-PRIEST EN JAREZ - Institut de Cancérologie de la Loire

    Saint-Priest-en-Jarez, 42271, France

  • Saint Aubin Les Elbeuf

    Saint-Aubin-lès-Elbeuf, 76503, France